Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)] + CEMIPLIMAB + Ubletamig

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)] + CEMIPLIMAB + Ubletamig
Treatment and conditionWhere it standsTrials
Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)] + CEMIPLIMAB + Ubletamig for endometrial neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)] + CEMIPLIMAB + Ubletamig for fallopian tube neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1